therefore , future efforts must be directed at defining the natural history and infectivity of individuals showing evidence of htlv iii or lav infection and toward specific antiviral therapy for those with infection and a vaccine for those at high risk for htlv iii infection and , consequently , aids .
C0009450
infection
C0019693
htlv iii infection